Quick Takeaways
- This page summarizes Rick E. Winningham's Form 4 filing for Theravance Biopharma, Inc. (TBPH).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 03 Apr 2026, 18:10.
Rick E. Winningham - 01 Apr 2026 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)
- Signature
- /s/ Brett A Grimaud, Attorney-in-Fact
- Issuer symbol
- TBPH
- Transactions as of
- 01 Apr 2026
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 03 Apr 2026, 18:10:24 UTC
- Previous filing
- 24 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Rick E. Winningham filed Form 4 for Theravance Biopharma, Inc. (TBPH) on 03 Apr 2026."
What Changed
- Previous filing in this sequence was filed on 24 Feb 2026.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Winningham Rick E | CHIEF EXECUTIVE OFFICER, Director | C/O THERAVANCE BIOPHARMA US, LLC, 901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO | /s/ Brett A Grimaud, Attorney-in-Fact | 03 Apr 2026 | 0001302443 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TBPH | Ordinary Shares | Award | +75,000 | +4.8% | $0.000000* | 1,651,094 | 01 Apr 2026 | Direct | ||
| holding | TBPH | Ordinary Shares | 23,400 | 01 Apr 2026 | As Custodian | ||||||
| holding | TBPH | Ordinary Shares | 92,567 | 01 Apr 2026 | By Trust |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.